rawfin.tv
CVS Restores Zepbound Coverage Following Eli Lilly Price Reduction
MarketsstocksAI Generated

CVS Restores Zepbound Coverage Following Eli Lilly Price Reduction

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

CVS Health will reinstate coverage for Eli Lilly & Co.'s obesity drug Zepbound on its insurance plans, following a significant price cut by the pharmaceutical giant. This move will grant over 10 million U.S. patients easier access to the weight-loss medication.

PharmaceuticalsHealthcareDrug PricingInsurance

Related Articles

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

stocks
S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks